Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA sequencing of MC38 mouse tumor tissue treated +/- drug and +/- immune cell depletion

PROVIDER: PRJNA477845 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7425060_1.fastq.gz	Fastqsanger.gz
	SRR7425060_2.fastq.gz	Fastqsanger.gz
	SRR7425070_1.fastq.gz	Fastqsanger.gz
	SRR7425070_2.fastq.gz	Fastqsanger.gz
	SRR7425080_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Project description:RNA sequencing of MC38 mouse tumor tissue with escalating drug dose

| PRJNA477829 | ENA

Project description:RNA sequencing of MC38 mouse tumor tissue with and without drug over time

| PRJNA477557 | ENA

Tumor microbial burden drives immune responses through regulation of Interferon signaling

Project description:To investigate the mechanisms involved in tumor microbial-associated immunotherapy sensitivity, we performed RNA sequencing on mouse MC38 tumor tissues upon local microbial depletion.

2026-05-08 | GSE329919 | GEO

Bulk RNA-Seq analysis of MC38 colon carcinoma cells and MC38 Bap1-knockout cells in vitro

Project description:In order to find out which genes Bap1 regulates to affect the anti-tumor immune response in MC38 colon carcinoma cell linewe knocked out the Bap1 gene in the MC38 cell line through CRISPR-Cas9 technology, RNA was directly isolated for RNA seq and were able to investigate gene expression.

2025-07-06 | E-MTAB-10588 | biostudies-arrayexpress

Pulsed photobiomodulation reprograms the tumor immune microenvironment to restore local T cell–mediated antitumor immunity

Project description:We have employed a single cell sequencing approach using 10X Genomics scRNA-seq to study MC38 tumor infiltrated immune cell under Photobiomodulation(PBM) treatment. PBM, also termed low-level laser therapy (LLLT), is a non-invasive, drug-free physical modality that uses defined light wavelengths to modulate cellular functions. This study represents the first transcriptomic analysis of how PBM reshapes the tumor microenvironment and inhibits MC38 tumor growth.

2026-04-07 | GSE318313 | GEO

UCA remodels tumor microenvironment(scRNA-Seq)

Project description:UCA remodeled tumor microenvironment through unknown features and mechanisms. Single-cell RNA-sequencing of mouse MC38 model treated with UCA was designed to depict a comprehensive cellular landscape and potential mechanisms.

2026-05-07 | GSE277030 | GEO

RNA-sequencing on sorted infiltrating CD8 T cells from vehicle or JHU083, pro-drug of 6-Diazo-5-oxo-L-norleucine (glutamine antagonist) treated MC38 (colon cancer) tumor bearing mice

Project description:RNA-sequencing was performed on sorted CD11b-CD11c-B220-CD45+TCRbeta+CD44+CD8+ TIL from vehicle or JHU083 treated MC38 tumor-bearing mice with or without JHU083, pro-drug of 6-Diazo-5-oxo-L-norleucine (glutamine antagonist) treatment for expression profiling

2020-02-24 | GSE120345 | GEO

CUT&Tag chromatin profiling of H2AK119Ub, H3K27me3, H3K27ac and H3K4me3 histone in MC38 colon carcinoma cell line

Project description:The deubiquitinating enzyme BAP1 can remove the ubiquitination modification of H2AK119. To reveal the mechanism by which Bap1 deletion in MC38 colon carcinoma cell line causes an anti-tumor immune response from the epigenetic level, we generated CUT&Tag data of H2AK119Ub, H3K27me3, H3K27ac and H3K4me3 histone in MC38-Bap1-Wildtype and MC38-Bap1-Knockout isolated from Rag2-deficient mice.

2025-07-06 | E-MTAB-10585 | biostudies-arrayexpress

Study on change of PBMC and tumor local immune map in colon cancer patients before and after general anesthesia based on single cell transcriptome sequencing

Project description:Interventions: Sevoflurane group:Nil;Propofol group:NIl Primary outcome(s): Heterogeneity of immune cell RNA spectrum in local tissue and peripheral blood of tumor Study Design: Non randomized control

| 2706736 | ecrin-mdr-crc

Bulk RNA-Seq analysis of MC38 colon carcinoma cells isolated from Rag2-deficient mice

Project description:To assess the role of Bap1 genes in MC38 colon carcinoma cell linewe knocked out the Bap1 gene in the MC38 cell line through CRISPR-Cas9 technology, MC38-Bap1-Wildtype and MC38-Bap1-Knockout tumor cells expressing BFP fluorescent protein were injected into Rag2-deficient mice subcutaneously. On the 10th day of tumor growth, BFP positive tumor cells were isolated and sorted by flow Cytometer. Bulk RNA-seq was performed on MC38-Bap1-Wildtype and MC38-Bap1-Knockout tumor cells for different gene signatures.

2025-07-06 | E-MTAB-10587 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data